An international research team profiled more than 7,500 tumor genomes, including small-bowel adenocarcinoma, colorectal cancer, and gastric cancer genomes.
At the AACR annual meeting, researchers presented results from the Phase II SUMMIT trial investigating the pan-HER-targeted therapy neratinib.
Caris will be on the lookout for pancreatic cancer patients with low DNA mismatch repair protein expression.
Lunatus will have exclusive rights to distribute GPS Cancer to physicians in the UAE, Saudi Arabia, Kuwait, Oman, Bahrain, Qatar, and Lebanon.
Under the agreement, researchers can use Foundation Medicine's assays to select patients eligible for Sarah Cannon Research Institute's clinical studies.
The researchers found that older people with clear arteries had noticeably higher levels of CXCL5 compared with older people with more plaque buildup.
A Baylor College of Medicine-led team uncovered nine genomic subtypes of kidney cancer that may help direct patients' treatments.
Younger NSLCL patients may benefit more from broad genomic profiling because they are more likely to have one of several targetable mutations.
The firm is conducting a multi-center prospective clinical study to validate its liquid biopsy ctDNA test, which it plans to launch for pharma customers this year and commercially in 2016.
The investment bank gave Foundation Medicine an Outperform rating, and Myriad Genetics and Genomic Health each a Market Perform rating.
Gene drives might run into biological resistance, the Economist reports.
Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.
Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.
In Science this week: full CRISPR locus integration complex structure, and more.